15-72686228-A-G
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_033028.5(BBS4):āc.1A>Gā(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000212 in 1,412,324 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ).
Frequency
Consequence
NM_033028.5 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BBS4 | NM_033028.5 | c.1A>G | p.Met1? | start_lost | Exon 1 of 16 | ENST00000268057.9 | NP_149017.2 | |
HIGD2B | NM_001350932.3 | c.-603T>C | upstream_gene_variant | ENST00000311755.6 | NP_001337861.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000113 AC: 2AN: 176590Hom.: 0 AF XY: 0.0000106 AC XY: 1AN XY: 93936
GnomAD4 exome AF: 0.00000212 AC: 3AN: 1412324Hom.: 0 Cov.: 31 AF XY: 0.00000287 AC XY: 2AN XY: 697916
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Bardet-Biedl syndrome Pathogenic:2
Variant summary: BBS4 c.1A>G (p.Met1Val) alters the initiation codon and is predicted to result either in absence of the protein or truncation of the encoded protein due to translation initiation at a downstream codon. Two of two in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 1.1e-05 in 176590 control chromosomes. To our knowledge, c.1A>G has not been reported in the literature in individuals affected with a clinical diagnosis of Bardet-Biedl Syndrome or BBS4-related conditions. These report(s) do not provide unequivocal conclusions about association of the variant with Bardet-Biedl Syndrome. However, deletion of exons 3-4 has been internally classified as pathogenic (ClinVar ID: 2501272). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 31980526). ClinVar contains an entry for this variant (Variation ID: 886465). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
This sequence change affects the initiator methionine of the BBS4 mRNA. The next in-frame methionine is located at codon 173. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with BBS4-related conditions. ClinVar contains an entry for this variant (Variation ID: 886465). This variant disrupts a region of the BBS4 protein in which other variant(s) (Deletion (Exons 3-4)) have been determined to be pathogenic (PMID: 11381270). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
BBS4-related disorder Pathogenic:1
The BBS4 c.1A>G variant is predicted to disrupt the translation initiation site (Start Loss). This variant was reported in a large cohort study integrating whole genome sequencing with deep phenotyping in adult participants (Table S1 in Hou et al 2020. PubMed ID: 31980526). This variant is reported in 0.0037% of alleles in individuals of Latino descent in gnomAD. This variant is interpreted as likely pathogenic. -
Bardet-Biedl syndrome 4 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at